The prognosis remains poor for patients living with idiopathic pulmonary fibrosis (IPF) and collaborations to enhance and expedite treatment options are crucial to patient survival. A recent collaboration has been announced by AstraZeneca to speed the discovery of new medicines for IPF, which is discussed in our latest flash briefing. To listen to the full briefing, click HERE.
What are your thoughts on this flash briefing?
An interesting, but complex and seemingly promising advancement for those of us living with IPF!
Pulmonary Fibrosis News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.